CytoDyn Market Cap

CytoDyn has a market cap or net worth of $375.37 million as of June 27, 2025. Its market cap has increased by 136.55% in one year.

Market Cap

375.37M

Enterprise Value

386.29M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.26

Market Cap Chart

Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 375.37M, an increase of 6,678.71%. That is a compound annual growth rate of 23.98%.

Market Cap History

Date	Market Cap	% Change
Jun 26, 2025	374.67M	178.29%
Dec 31, 2024	134.63M	-29.42%
Dec 29, 2023	190.74M	2.63%
Dec 30, 2022	185.85M	-72.64%
Dec 31, 2021	679.28M	-78.86%
Dec 31, 2020	3.21B	695.20%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.59B
Elite Pharmaceuticals	801.20M
Veradigm	764.23M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	628.15M
American Oncology Network	446.28M
Glass House Brands	389.15M
Northwest Biotherapeutics	375.99M

Market Cap Rankings